# DeLorean Artificial Intelligence

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/delorean-artificial-intelligence

- Industry: IT Infrastructure
- Headquarters: Palm Beach, US
- Website: www.deloreanai.com
- Total disclosed funding: $11M
- Latest round: Series A (Aug 1, 2023)
- Investors on record: 3

## About

Based in Florida, US, and founded in 2019 by founder Severence M. Maclaughlin, DeLorean Artificial Intelligence provides AI applications, from natural language processing and computer vision to machine learning and predictive analytics, to the finance, healthcare, manufacturing, and technology sectors. In August 2023, DeLorean Artificial Intelligence raised USD 7.55 million in series A funding led by investor Sopris Venture Capital, with participation from Pinta Capital Partners.

DeLorean's Artificial Intelligence product line includes Medical AI, a technology that excels in predicting, generating next-best actions, and presenting outputs in an easily understandable format. It offers solutions across the spectrum of healthcare, including disease onset management, care gap analysis, patient health directionality, disease journey mitigation, cost and utilisation forecasts, and more. The technology caters to specific disease states such as renal AI, diabetes AI, and cardio AI.
The company also offers Sales AI, which is designed to address the most challenging sales problems. It enables users to predict the outcome of deals, identify potential roadblocks in the sales cycle, and recommend actions to move deals towards success. Moreover, sales AI offers increased visibility into operations, aiding in quarterly revenue predictions and improving forecasting. In addition, the firm also offers TAPE (Ticket Analysis Prediction Engine), enabling organisations to harness the power of predictive analytics to enhance their operational activity and reduce manual efforts. By analysing internal IT data, TAPE AI generates real-time, actionable insights that empower businesses to make informed decisions, optimise processes, and improve end-to-end business continuity.
 
The company plans to use the August 2023 funding to accelerate the expansion and adoption of its medical AI product in various markets and extend its team.

## Funding rounds

- Series A, Aug 1, 2023, $7.5M — Sopris Venture Capital, Pinta Capital Partners
- Seed, Oct 1, 2022, $3M — Mindful Venture Capital

## Investors

- Mindful Venture Capital (https://capitalatlas.ai/funds/mindful-venture-capital) — Seed
- Sopris Venture Capital (https://capitalatlas.ai/funds/sopris-venture-capital) — Series A
- Pinta Capital Partners (https://capitalatlas.ai/funds/pinta-capital-partners) — Series A